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ABSTRACT 
 
In the present research work colon formulation of Pinaverium targeted to colon by using various polymers 
developed. To achieve pH-independent drug release of Pinaverium, pH modifying agents (buffering agents) 
were used. Colon targeted tablets were preparedin two steps. Initially core tablets were prepared and then 
the tablets were coated by using different pH dependent polymers. Ethyl cellulose, Eudragit RLPO and S100 
were used as enteric coating polymers. The precompression blend of all formulations was subjected to 
various flow property tests and all the formulations were passed the tests. The tablets were coated by using 
polymers and the coated tablets were subjected to various evaluation techniques. The tablets were passed 
all the tests. Among all the formulations F6 formulation was found to be optimized as it was retarded the 
drug release up to 18 hours and showed maximum of 98.45% drug release. It followed first order kinetics 
mechanism. 
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INTRODUCTION 
Now a days a novel oral colon-specific drug delivery 
system (CDDS) has been developed as one of the site-
specific drug delivery systems1. This delivery system, 
by means of combination of one or more controlled 
release mechanisms, hardly releases drug in the 
upper part of the gastrointestinal (GI) tract, but 
rapidly releases drug in the colon following oral 
administration2. First as for treating localized colonic 
diseases, i.e. ulcerative colitis, Crohn’s disease and 
constipation etc., the optimal drug delivery system, 
such as CDDS, should selectively deliver drug to the 
colon, but not to the upper GI tract3. Second, the colon 
is referred to as the optimal absorption site for 
protein and polypeptide after oral administration, 
because of the existence of relatively low proteolytic 
enzyme activities and quite long transit time in the 
colon. Finally, CDDS would be advantageous when a 
delay in absorption is desirable from a 
therapeutically point of view, as for the treatment of 
diseases that have peak symptoms in the early 
morning and that exhibit circadian rhythms, such as 
nocturnal asthma, angina and rheumatoid arthritis. 
Pinaverium is a spasmolytic agent used for functional 
gastrointestinal disorders4. It is a quaternary 
ammonium compound that acts as an atypical 
calcium antagonist to restore normal bowel function. 
It is shown to relieve GI spasm and pain, transit 
disturbances and other symptoms related to motility 
disorders and may be considered as effective first-
line therapy for patients with irritable bowel 
syndrome (IBS)5. Pinaverium bromide is the common 
ingredient in formulations, mostly as oral tablets. 
MATERIALS AND METHODS 
Pinaverium was obtained as gift sample from Natco 
LABS, Hyderabad. Ethyl Cellulose was obtained from 
Signet Chemical Corporation, Mumbai, India. 
Eudragit RLPO, Eudragit L-100 Cross carmellose 
sodium Magnesium Stearate and Microcrystalline 
cellulose was purchased from Merck Specialties Pvt 
Ltd, Mumbai, India. 
Analytical method development 
a) Determination of absorption maxima: A 
solution of containing the concentration 10 µg/ ml 
was prepared in 0.1N Hcl, 7.4 pH & phosphate buffer 
6.8 pH respectively, UV spectrum was taken using 
Double beam UV/VIS spectrophotometer. The 
solution was scanned in the range of 200 – 400. 
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b) Preparation calibration curve: 10mg of drug 
was accurately weighed and dissolved in 10ml of 
0.1N Hcl, 7.4 pH, and 6.8 pH in 10 ml volumetric flask, 
to make (1000 µg/ml) standard stock solution (1). 
Then 1 ml stock solution (1) was taken in another 10 
ml volumetric flask to make (100 µg/ml) standard 
stock solution (2), then again 1 ml of stock solution 
(2) was taken in another 10 ml volumetric flask and 
then final concentrations were prepared 2, 4, 6, 8, 10, 
12, 14, 16, 18 ,and 20µg/ml with 0.1N Hcl, 7.4 pH, and 
6.8 pH. The absorbance of standard solution was 
determined using UV/ VIS spectrophotometer at 
270nm. Linearity of standard curve was assessed 
from the square of correlation coefficient (r2) which 
determined by least-square linear regression 
analysis. 
Table 1: Observations for graph of Pinaverium in 7.4 
pH Simulated Intestinal Fluid (nm) 
S.No Conc.(mg/l) 
Abs 
7.4 pH 0.1N Hcl 6.8 pH 
1 0 0 0 0.148 
2 2 0.129 0.138 0.275 
3 4 0.204 0.256 0.379 
4 6 0.284 0.376 0.481 
5 8 0.372 0.461 0.621 
6 10 0.566 0.582 0.859 
7 12 0.625 0.824 0.148 
 
Figure 1: Standard graph of Pinaverium in 0.1N Hcl 
 
Figure 2: Standard graph of Pinaverium in 6.8 pH 
 
Figure 3: Standard graph of Pinaverium in 7.4 pH 
 
Figure 4: FT-IR spectrum of pure drug 
 
Figure 5: FTIR spectrum of optimized formulation 
Drug – excipient compatibility studies 
Fourier Transform Infrared (FTIR) Spectroscopy: 
The physical properties of the physical mixture were 
compared with those of plain drug. Samples was 
mixed thoroughly with 100 mg potassium bromide IR 
powder and compacted under vacuum at a pressure 
of about 12 psi for 3 minutes. The resultant disc was 
mounted in a suitable holder in Perkin Elmer IR 
spectrophotometer and the IR spectrum was 
recorded from 3500 cm to 500 cm. The resultant 
spectrum was compared for any spectrum changes. 
Preformulation parameters 
The quality of tablet, once formulated by rule, is 
generally dictated by the quality of physicochemical 
properties of blends. There are many formulations  
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and process variables involved in mixing and all these 
can affect the characteristics of blends produced6.  
Angle of repose: The frictional force in a loose 
powder can be measured by the angle of repose. It is 
defined as, the maximum angle possible between the 
Table 2: Composition of coating layer 
S.No Ingredient name F1 F2 F3 F4 F5 F6 F7 F8 F9 
1 Ethyl cellulose (mg) 50 100 - - - - 50 - 50 
2 Eudragit RLPO (mg) - - 50 100 - - 50 50 - 
3 Eudragit L 100 (mg) - - - - 50 100 - 50 50 
4 Magnesium stearate (mg) 3 3 3 3 3 3 3 3 3 
5 Talc (mg) 3 3 3 3 3 3 3 3 3 
6 MCC pH 102 (mg) q.s q.s q.s q.s q.s q.s q.s q.s q.s 
7 Total weight 280 280 280 280 280 280 280 280 280 












F1 26.01 0.55 0.645 14.72 0.85 
F2 24.8 0.57 0.66 13.63 0.86 
F3 26.05 0.53 0.606 14.19 0.838 
F4 24.19 0.531 0.613 13.37 0.866 
F5 26.24 0.549 0.641 14.35 0.856 
F6 23.25 0.564 0.666 15.31 0.854 
F7 27.08 0.581 0.671 13.41 0.865 
F8 25.12 0.567 0.654 13.12 0.845 
F9 25.45 0.571 0.689 13.28 0.855 













F1 402.5 4.5 0.52 4.8 99.76 
F2 405.4 4.2 0.54 4.9 99.45 
F3 398.6 4.4 0.51 4.9 99.34 
F4 410.6 4.5 0.55 4.9 99.87 
F5 409.4 4.4 0.56 4.7 99.14 
F6 410.7 4.2 0.45 4.5 98.56 
F7 402.3 4.1 0.51 4.4 98.42 
F8 401.2 4.3 0.49 4.7 99.65 
F9 398.3 4.5 0.55 4.6 99.12 
Table 5: In-vitro Drug Release profile for coated formulations (F1-F9) 
Time(hrs) F1 F2 F3 F4 F5 F6 F7 F8 F9 
0.5 3.77 9.14 5.12 8.23 2.71 5.46 4.11 3.11 5.54 
1 10.51 16.76 12.45 17.55 11.51 17.54 12.35 7.15 12.17 
2 18.4 25.77 17.47 22.42 19.4 24.72 19.42 14.21 24.58 
3 24.15 29.42 23.42 28.11 23.17 31.76 25.12 27.54 33.19 
4 32.13 34.64 29.18 36.67 31.18 37.62 32.15 35.45 39.79 
5 37.91 41.32 36.71 48.71 36.91 46.87 36.36 45.21 48.69 
6 42.92 49.12 41.78 56.86 42.92 49.09 40.54 53.77 52.75 
7 48.18 52.77 48.89 59.49 49.16 53.72 46.39 56.34 54.38 
8 54.32 56.85 52.22 62.46 53.32 56.73 51.21 58.73 56.54 
9 59.93 59.32 54.42 65.19 58.93 61.41 57.54 61.69 58.28 
10 63.82 61.98 58.34 69.42 62.85 63.32 62.36 63.54 62.19 
11 65.77 63.27 60.42 71.12 64.71 68.13 64.28 65.15 64.14 
12 68.22 65.72 62.47 72.41 66.34 78.28 68.03 66.49 66.68 
13 69.35 69.35 64.28 73.89 68.98 82.54 72.35 68.45 69.84 
14 71.23 72.65 66.38 75.67 71.26 84.32 74.85 69.87 72.36 
15 73.63 74.28 69.45 77.98 73.45 87.98 77.21 72.45 74.38 
16 75.39 76.37 72.56 79.82 75.28 92.98 79.45 74.36 77.45 
17 77.28 78.36 75.23 81.25 79.32 95.64 82.37 76.29 78.52 
18 79.12 82.21 77.87 83.65 84.36 98.45 85.87 79.34 83.28 
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surface of the pile of the powder and the horizontal 
plane. If more powder is added to the pile, it slides 
down the sides of the pile until the mutual friction of 
the particles producing a surface angle, is in 
equilibrium with the gravitational force. The fixed 
funnel method was employed to measure the angle of 
repose. A funnel was secured with its tip at a given 
height (h), above a graph paper that is placed on a flat 
horizontal surface. 
The blend was carefully pored through the funnel 
until the apex of the conical pile just touches the tip of 
the funnel. The radius (r) of the base of the conical 
pile was measured. The angle of repose was 
calculated using the following formula: 
Tan θ = h / r 
Where; Tan θ = Angle of repose, h = Height of the 
cone, r = Radius of the cone base 
Bulk density: Bulk density, is defined as the mass of 
the powder divided by the bulk volume and is 
expressed as gm/cm3. 10 gm powder blend was 
sieved and introduced into a dry 20 ml cylinder, 
without compacting. The powder was carefully 
leveled without compacting and the unsettled 
apparent volume Vo was read. The bulk density was 
calculated using the formula: 
Bulk Density = M / Vo 
M = weight of sample, Vo = apparent volume of 
powder 
Tapped density: After carrying out the procedure as 
given in the measurement of bulk density the cylinder 
containing the sample was tapped using a suitable 
mechanical tapped density tester that provides 100 
drops per minute and this was repeated until 
difference between succeeding measurement is less 
than 2 % and then tapped volume, V measured, to the 
nearest graduated unit. The tapped density was 
calculated, in gm per L, using the formula: 
Tap = M / V 
Where, Tap= Tapped Density, M = Weight of sample, 
V= Tapped volume of powder 
Measures of powder compressibility: 
The Compressibility Index (Carr’s Index) is a measure 
of the propensity of a powder to be compressed. It is 
determined from the bulk and tapped densities 
Carr’s Index = [(tap - b) / tap] × 100 
Where, b = Bulk Density, Tap = Tapped Density 
Composition of core tablet7: Total weight of core 
tablet was fixed as 7.5 mg. The tablets are prepared 
by using 6mm flat punch. Then the prepared core 
tablets are subjected to compression coating by using 
various compositions of polymers. 
Formulation of compression coated tablets8: The 
prepared core tablets were subjected to compression 
coating by using various compositions of polymers 
such as Ethyl cellulose, Eudragit L 100 and Eudragit S 
100 as coating materials. The composition of coating 
layer is given in below table. 
Compression coating layer was divided into two 
equal portions i.e., 140mg of each quantity .Half of the 
quantity of powder blend was placed in the die cavity, 
core tablet was placed exactly in the middle of die 
cavity and then remaining quantity of powder blend 
was placed over the core tablet so that the powder 
blend should cover all the sides and top side of core 
tablet uniformly. Then the tablets are compressed by 
using 10mm flat surfaced punch using 8 station tablet 
punching machine with the hardness of 4-4.5 
kg/cm2.Then the prepared compression coated 
tablets are evaluated for various post compression 
parameters as per standard specifications9. 
Evaluation of post compression parameters for 
prepared tablets 
The designed formulation compression coated 
tablets were studied for their physicochemical 
properties like weight variation, hardness, thickness, 
friability and drug content10. 
Weight variation test: To study the weight variation, 
twenty tablets were taken and their weight was 
determined individually and collectively on a digital 
weighing balance. The average weight of one tablet 
was determined from the collective weight. The 
weight variation test would be a satisfactory method 
of deter mining the drug content uniformity. Not 
more than two of the individual weights deviate from 
the average weight by more than the percentage 
shown in the following table and none deviate by 
more than twice the percentage. The mean and 
deviation were determined. The percent deviation 
was calculated using the following formula. 
% Deviation = (Individual weight – Average weight / 
Average weight) × 100 
Hardness: Hardness of tablet is defined as the force 
applied across the diameter of the tablet in order to 
break the tablet. The resistance of the tablet to 
chipping, abrasion or breakage under condition of 
storage transformation and handling before usage 
depends on its hardness. For each formulation, the 
hardness of three tablets was determined using 
Monsanto hardness tester and the average is 
calculated and presented with deviation. 
Friability: It is measured of mechanical strength of 
tablets. Roche friabilator was used to determine the 
friability by following procedure. Pre weighed tablets 
were placed in the friabilator. The tablets were 
rotated at 25 rpm for 4 minutes (100 rotations). At 
the end of test, the tablets were re weighed, loss in the 
weight of tablet is the measure of friability and is 
expressed in percentage as 
% Friability = [(W1-W2) / W] × 100 
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Where, W1 = Initial weight of three tablets 
W2 = Weight of the three tablets after testing 
Determination of drug content: Ten tablets were 
finely powdered quantities of the powder equivalent  
to one tablet weight of Pinaverium were accurately 
weighed, transferred to a 100 ml volumetric flask 
containing 50 ml water and were allowed to stand to 
ensure complete solubility of the drug. The mixture 
was made up to volume with water. The solution was 
suitably diluted and the absorption was determined 
by UV –Visible spectrophotometer. The drug 
concentration was calculated from the calibration 
curve. 
In vitro drug release studies 
Drug release studies of Compression coated 
Pinaverium tablets: The release of Pinaverium from 
coated tablets was carried out using USP paddle-type 
dissolution apparatus at a rotation speed of 50 rpm, 
and a temperature of 37±0.5 °C. For tablets, 
simulation of gastrointestinal transit conditions was 
achieved by using different dissolution media. Thus, 
drug release studies were conducted in simulated 
gastric fluid (SGF, pH 1.2) for the first 2 hours as the 
average gastric emptying time is about 2 hours. Then, 
enzyme- free simulated intestinal fluid ( SIF, pH 6.8 ) 
was used up to 12 hours to mimic colonic pH 
conditions and finally the dissolution medium was 
replaced with enzyme- free simulated intestinal fluid 
( SIF, pH 7.4 ) and tested for drug release up to 18 
hours. Drug release was measured from compression 
coated Pinaverium tablets, added to 900 ml of 
dissolution medium. 5 ml of sample was withdrawn 
every time and replaced with fresh medium, samples 
withdrawn at various time intervals were analyzed 
spectrophotometrically at 275 nm and 270 nm 
respectively. All dissolution runs were performed for 
six batches. The results were given with deviation. 
Application of Release Rate Kinetics To 
Dissolution Data: Various models were tested for 
explaining the kinetics of drug release. To analyze the 
mechanism of the drug release rate kinetics of the 
dosage form, the obtained data were fitted into zero-
order, first order, Higuchi, and Korsmayer-Peppa’s 
release model. 
Zero order release rate kinetics: To study the zero–
order release kinetics the release rate data are fitted 
to the following equation. 
F = Kot 
Where, ‘F’ is the drug release at time‘t’, and ‘Ko’ is the 
zero order release rate constant.  
The plot of % drug release versus time is linear. 
First order release rate kinetics: The release rate 
data are fitted to the following equation 
Log (100-F) = kt 
A plot of log cumulative percent of drug remaining to 
be released vs. time is plotted then it gives first order 
release. 
Higuchi release model: To study the Higuchi release 
kinetics, the release rate data were fitted to the 
following equation. 
 F = k t1/2 
Where, ‘k’ is the Higuchi constant. 
In higuchi model, a plot of % drug release versus 
square root of time is linear. 













0 0 0   2.000 
5.46 0.5 0.707 0.737 -0.301 1.976 
17.54 1 1.000 1.244 0.000 1.916 
24.72 2 1.414 1.393 0.301 1.877 
31.76 3 1.732 1.502 0.477 1.834 
37.62 4 2.000 1.575 0.602 1.795 
46.87 5 2.236 1.671 0.699 1.725 
49.09 6 2.449 1.691 0.778 1.707 
53.72 7 2.646 1.730 0.845 1.665 
56.73 8 2.828 1.754 0.903 1.636 
61.41 9 3.000 1.788 0.954 1.586 
63.32 10 3.162 1.802 1.000 1.564 
68.13 11 3.317 1.833 1.041 1.503 
78.28 12 3.464 1.894 1.079 1.337 
82.54 13 3.606 1.917 1.114 1.242 
84.32 14 3.742 1.926 1.146 1.195 
87.98 15 3.873 1.944 1.176 1.080 
92.98 16 4.000 1.968 1.204 0.846 
95.64 17 4.123 1.981 1.230 0.639 
98.45 18 4.243 1.993 1.255 0.190 
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Korsmayer and Peppa’s release model: The 
mechanism of drug release was evaluated by plotting 
the log percentage of drug released versus log time 
according to Korsmayer- Peppa’s equation. The 
exponent ‘n’ indicates the mechanism of drug release 
calculated through the slope of the straight Line. 
Mt/ M∞ = K tn 
Where, Mt/ M∞ is fraction of drug released at time ‘t’, 
k represents a constant, and ‘n’ is the diffusional 
exponent, which characterizes the type of release 
mechanism during the dissolution process. For non-
Fickian release, the value of n falls between 0.5 and 
1.0; while in case of Fickian diffusion, n = 0.5; for zero-
order release (case II transport), n=1; and for 
supercase II transport, n > 1. In this model, a plot of 
log (Mt/ M∞) versus log (time) is linear. 
Hixson-Crowell release model: (100-Qt)1/3 = 
1001/3- KHC.t 
Where, k is the Hixson-Crowell rate constant. 
Hixson-Crowell model describes the release of drugs 
from an insoluble matrix through mainly erosion. 
(Where there is a change in surface area and diameter 
of particles or tablets). 
 
Figure 12: First order release kinetics graph of F6 
 
Figure 6: Dissolution of formulations F1-F3 
 
Figure 7: Dissolution of formulations F4-F6 
 
Figure 8: Dissolution of formulations F7-F9 
 
Figure 9: Zero order release kinetics graph of F6 
 
 
Figure 10: Higuchi release kinetics graph of F6 
 
 
Figure 11: Korsmayer peppa’s graph of F6 
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RESULTS AND DISCUSSION 
Analytical Method: Graphs of Pinaverium was taken 
in Simulated Gastric fluid (pH 1.2) and Simulated 
Intestinal Fluid (pH 6.8 and 7.4) 
Pinaverium blend was subjected to various pre-
formulation parameters The apparent bulk density 
and tapped bulk density values ranged from 0.52 to 
0.581 and 0.606 to 0.671 respectively. According to 
Tables 7.4, the results of angle of repose and 
compressibility index (%) ranged from 32.74±0.12 to 
37.08±0.96 and 13.37±0.38 to 14.72±0.62 
respectively. The results of angle of repose (<35) and 
compressibility index (<23) indicates fair to passable 
flow properties of the powder mixture. These results 
show that the powder mixture has good flow 
properties. The formulation blend was directly 
compressed to tablets and in-vitro drug release 
studies were performed. 
Quality Control Parameters For compression 
coated tablets: 
Tablet quality control tests such as weight variation, 
hardness, and friability, thickness, and drug release 
studies in different media were performed on the 
compression coated tablet. Total weight of tablet 
including core is 300 mg. 
Application of Release Rate Kinetics to 
Dissolution Data: 
Various models were tested for explaining the 
kinetics of drug release. To analyze the mechanism of 
the drug release rate kinetics of the dosage form, the 
obtained data were fitted into zero-order, first order, 
Higuchi, and Korsmayer - Peppa’s release model. 
CONCLUSION 
In the present research work of Pinaverium targeted 
to colon by using various polymers developed. To 
achieve pH-independent drug release of Pinaverium, 
pH modifying agents (buffering agents) were used. 
Colon targeted tablets were prepared in two steps. 
Initially core tablets were prepared and then the 
tablets were coated by using different pH dependent 
polymers. Ethyl cellulose, Eudragit L100 and S100 
were used as enteric coating polymers. The 
precompression blend of all formulations was 
subjected to various flow property tests and all the 
formulations were passed the tests. The tablets were 
coated by using polymers and the coated tablets were 
subjected to various evaluation parameters. The 
tablets were passed all the tests. Among all the 
formulations F6 formulation was found to be 
optimized as it was retarded the drug release up to 18 
hours and showed maximum of 98.45% drug release. 
It followed first order kinetics mechanism with 
followed by non-fickian diffusion.  The results clearly 
stated that the Pinaverium colon release tablets can 
sustain the release of the drug with a maximum 
release and it can be concluded that Pinaverium 
tablets were successfully prepared for colon 
targeting. 
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